Dicarba-closo-dodecaboranes_NNS
as_IN
a_DT
pharmacophore_NN
._.

Retinoidal_JJ
antagonists_NNS
and_CC
potential_JJ
agonists_NNS
._.

Synthesis_NN
and_CC
biological_JJ
evaluation_NN
of_IN
the_DT
first_JJ
dicarba-closo-dodecaborane_NN
-LRB-_-LRB-
carborane_NN
-RRB-_-RRB-
derivatives_NNS
of_IN
retinoids_NNS
are_VBP
described_VBN
._.

Their_PRP$
retinoidal_JJ
activity_NN
were_VBD
examined_VBN
in_IN
terms_NNS
of_IN
the_DT
differentiation-inducing_JJ
ability_NN
toward_IN
human_JJ
promyelocytic_JJ
leukemia_NN
HL-60_NN
cells_NNS
._.

High_JJ
retinoidal_JJ
activity_NN
-LRB-_-LRB-
agonist_NN
or_CC
antagonist_NN
for_IN
retinoic_JJ
acid_NN
receptor_NN
-LRB-_-LRB-
RAR_NN
-RRB-_-RRB-
requires_VBZ
a_DT
carboxylic_JJ
acid_NN
moiety_NN
and_CC
an_DT
appropriate_JJ
hydrophobic_JJ
group_NN
located_JJ
at_IN
a_DT
suitable_JJ
position_NN
on_IN
the_DT
molecule_NN
._.

The_DT
4-carboranyl-substituted_JJ
compounds_NNS
-LRB-_-LRB-
7_CD
,_,
11_CD
-RRB-_-RRB-
showed_VBD
antagonistic_JJ
activity_NN
but_CC
no_DT
agonistic_JJ
activity_NN
even_RB
in_IN
the_DT
presence_NN
of_IN
the_DT
potent_JJ
synergist_NN
HX630_NN
._.

On_IN
the_DT
other_JJ
hand_NN
,_,
the_DT
3-carboranyl-substituted_JJ
compounds_NNS
-LRB-_-LRB-
8_CD
,_,
12_CD
-RRB-_-RRB-
showed_VBD
potential_JJ
agonistic_JJ
activity_NN
,_,
but_CC
no_DT
antagonistic_JJ
activity_NN
._.

The_DT
results_NNS
indicates_VBZ
that_IN
carboranes_NNS
are_VBP
applicable_JJ
as_IN
the_DT
hydrophobic_JJ
moiety_NN
of_IN
biologically_RB
active_JJ
molecules_NNS
._.

